Stay updated on Vahelva Respimat in Korean COPD Patients Clinical Trial

Sign up to get notified when there's something new on the Vahelva Respimat in Korean COPD Patients Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Vahelva Respimat in Korean COPD Patients Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The page now presents the ClinicalTrials.gov record for a completed Korean COPD surveillance study of Vahelva Respimat, with study design, eligibility, outcome measures, record dates, and document and data-sharing information.
    Difference
    53%
    Check dated 2026-11-09T12:51:53.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.2 to v3.8.0. The study page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-02T12:17:15.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    A site-wide NIH announcement appears above the ClinicalTrials.gov navigation, linking to transition updates and FAQs and saying that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence.”
    Difference
    1%
    Check dated 2026-10-26T12:14:13.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.1 to v3.7.2. The page still displays a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-19T12:43:48.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The footer’s site revision label changes from v3.7.0 to v3.7.1 on an otherwise unchanged 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-12T14:00:34.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The page now renders a 403 Forbidden error, replacing the expected study details with a generic error page. The header shows '403' and '403 Forbidden' with a Home link and site revision info, indicating the record is not accessible.
    Difference
    19%
    Check dated 2026-09-21T22:17:30.000Z thumbnail image

Stay in the know with updates to Vahelva Respimat in Korean COPD Patients Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Vahelva Respimat in Korean COPD Patients Clinical Trial page.